Page last updated: 2024-08-16

ono 1078 and hydroxyproline

ono 1078 has been researched along with hydroxyproline in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Okunishi, H; Shimbori, C; Shiota, N	1

Other Studies

1 other study(ies) available for ono 1078 and hydroxyproline

Article	Year
Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice. International archives of allergy and immunology, 2012, Volume: 158, Issue:3 Topics: Animals; Bronchoalveolar Lavage Fluid; Chromones; Cytokines; Disease Progression; Female; Hydroxyproline; Inflammation; Leukotriene Antagonists; Lung; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Silicon Dioxide; Treatment Outcome	2012

Article

Year

Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice.

International archives of allergy and immunology, 2012, Volume: 158, Issue:3

Topics: Animals; Bronchoalveolar Lavage Fluid; Chromones; Cytokines; Disease Progression; Female; Hydroxyproline; Inflammation; Leukotriene Antagonists; Lung; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Silicon Dioxide; Treatment Outcome

2012